We are monitoring the impact of COVID-19 on Europe DNA Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date June, 2021
ID: 11658
Share on
Share on

Europe DNA Sequencing Market Research Report – Segmented By Product & Services, Technology, Workflow, Application, End User, and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: June, 2021
ID: 11658
Pages: 100

Europe DNA Sequencing Market Size (2021 to 2026)

The European DNA sequencing market size is forecasted to showcase a CAGR of 18.4% between 2021 to 2026.

DNA sequencing is employed in various applications, including biomarker identification, oncology research, personalized treatment, forensics, and more. Due to a growth in sequencing applications, a rise in the number of genome mapping programs throughout the world, increasing R&D expenditure, and technological advancements in DNA sequencing, demand for DNA sequencing has increased significantly. Bioinformatics developments, growing prevalence of viral infections like SARS and COVID-19, increased applications of NGS (Next-generation Sequencing) and WGS (Whole-genome Sequencing), and growing cancer incidences globally are fueling the European DNA sequencing market expansion. Due to technical developments in DNA sequencing platforms, cloud computing applications to store DNA sequencing data, data storage & management, and other fields, DNA sequencing, and the biotechnology sector are becoming more prominent. The overall market is predicted to rise due to main reasons such as increased research and development activities employing NGS technologies, expanding uses of NGS in clinical diagnostics, and discovery applications requiring NGS technology.

The growth of the DNA sequencing market may be hindered by issues about accuracy and standards, as well as ethical and legal restrictions. Social and ethical issues, bioinformatics constraints, a shortage of skilled professionals, and diagnostic testing accuracy are among the market growth restraints. The market for next-generation sequencing is encountering hurdles since many customers cannot afford the test due to its high price. Therefore, the high cost of next-generation sequencing technology is a major obstacle to the market's expansion.

COVID-19 Impact on the Europe DNA Sequencing Market:

The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. For many healthcare reimbursement facilities, DNA sequencings are likely to become more popular throughout the forecast period. As a result of these, next-generation sequencing is expected to become more widely used in healthcare diagnostics. In March 2020, a COVID-19 genome sequencing partnership was created for large-scale viral analysis. The market is expected to increase substantially during the forecast period (2021 to 2026), owing to the rising DNA sequencing-based research and development efforts in the development of diagnostic tools or effective therapies for COVID-19. Next-generation sequencing (NGS) technique for qualitative identification of SARS-CoV-2 nucleic acid in upper respiratory specimens from people suspected of having COVID-19. Throughout the COVID-19 epidemic, governments worldwide have collaborated with the private sector to bring next-generation sequencing (NGS) technology to market as a viable diagnostic tool.

This research report on the European DNA sequencing market has been segmented and sub-segmented into the following categories.

By Product & Services:

  • Consumables
  • Instruments
  • Services

By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agri genomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Due to the growing rates of an aging population suffering from cancer, sedentary lifestyle, and an efficient reimbursement scenario, the European DNA sequencing market is expected to drive the growth of the DNA Sequencing Market in the coming years. The presence of skilled researchers and high investment in research and development made Europe the most significant market. Germany has made significant investments in healthcare and medical research in response to the rising prevalence of diseases. The German DNA sequencing market is expected to grow as a result of this. Pharmaceutical and biotechnology businesses in Italy are increasing their market share and making major expenditures to meet the growing demand for DNA sequencing. The fast-paced expansion of the R&D sector and industry-wide partnerships focusing on a variety of applications and research activities are expected to contribute to market expansion. In addition, the government's preference for home care services and educational initiatives is expected to aid in driving high incontinence device market income to this region.

KEY MARKET PLAYERS:

Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc. are a few of dominating companies in the Europe DNA sequencing market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. Products and Services
      1. Consumables
      2. Instruments
      3. Services
      4. Y-o-Y Growth Analysis, By Products and Services
      5. Market Attractiveness Analysis, By Products and Services
      6. Market Share Analysis, By Products and Services
    2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
      3. Whole Genome Sequencing (WGS)
      4. Whole Exome Sequencing (WES)
      5. Targeted Sequencing & Resequencing
      6. Third Generation DNA Sequencing  
      7. Single-Molecule Real-Time Sequencing (SMRT)
      8. Nanopore Sequencing
      9. Y-o-Y Growth Analysis, By Technology
      10. Market Attractiveness Analysis, By Technology
      11. Market Share Analysis, By Technology
    3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
      4. Y-o-Y Growth Analysis, By Workflow
      5. Market Attractiveness Analysis, By Workflow
      6. Market Share Analysis, By Workflow
    4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agri genomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10. Market Attractiveness Analysis, By Application
      11. Market Share Analysis, By Application
    5. By End-User
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
      6. Y-o-Y Growth Analysis, By End User
      7. Market Attractiveness Analysis, By End User
      8. Market Share Analysis, By End User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Turkey
      13. Czech Republic
      14. Rest of Europe
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Abbott Laboratories
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Agilent Technologies, Inc.
    3. Danaher Corporation (Beckman Coulter, Inc.)
    4. F. Hoffmann-La Roche Ltd
    5. Illumina, Inc.
    6. LI-COR Biosciences, Inc.
    7.  Pacific Biosciences of California, Inc.
    8.  SIEMENS AG
    9. PerkinElmer Inc.,
    10. Thermo Fisher Scientific, Inc.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations, and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of products and services, workflow, application, and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine an Industry's overall profitability, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  2. Europe Consumables Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Services Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Europe Sanger Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Next-Generation Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Whole Genome Sequencing (WGS) Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Whole Exome Sequencing (WES) Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Targeted Sequencing & Resequencing Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Third Generation DNA Sequencing   Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Single-Molecule Real-Time Sequencing (SMRT) Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Nanopore Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  15. Europe Pre-sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  16. Europe Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  17. Europe Data Analysis Market, By Region, From 2021 to 2026 (USD Billion)
  18. Europe DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  19. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. Europe Reproductive Health Market, By Region, From 2021 to 2026 (USD Billion)
  21. Europe Clinical Investigation Market, By Region, From 2021 to 2026 (USD Billion)
  22. Europe Agrigenomics & Forensics Market, By Region, From 2021 to 2026 (USD Billion)
  23. Europe HLA Typing/Immune System Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  24. Europe Metagenomics, Epidemiology & Drug Development Market, By Region, From 2021 to 2026 (USD Billion)
  25. Europe Consumer Genomics Market, By Region, From 2021 to 2026 (USD Billion)
  26. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  27. Europe DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  28. Europe Academic Research Market, By Region, From 2021 to 2026 (USD Billion)
  29. Europe Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  30. Europe Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  31. Europe Pharmaceutical & Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  32. Europe Other Users Market, By Region, From 2021 to 2026 (USD Billion)
  33. U.K. DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  34. U.K. DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  35. U.K. DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  36. U.K. DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  37. U.K. DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  38. Germany DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  39. Germany DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  40. Germany DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  41. Germany DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  42. Germany DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  43. France DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  44. France DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  45. France DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  46. France DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  47. France DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  48. Italy DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  49. Italy DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  50. Italy DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  51. Italy DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  52. Italy DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  53. Spain DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  54. Spain DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  55. Spain DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  56. Spain DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  57. Spain DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample